Attitude of the Adult Patient With Atopic Dermatitis to the Disease and Its Treatment: The ACTIDA Study

Betlloch, I.; Izu, R.; Lleonart, M.; Ferrer, M.; Ferrando, J.

doi:10.1016/S1578-2190(10)70600-4

Article information

Statistics

Abstract

Objective

To determine the attitude of adult patients with atopic dermatitis (AD) to their disease and its treatment.

Material and methods

A multicenter, cross-sectional study was performed in patients with at least 2 outbreaks of AD in the previous year.

Results

Two hundred twenty-seven dermatologists recruited 1441 analyzable patients, the majority women, with a mean of 3.6 outbreaks per year. Most of the patients (97.2%) indicated that they always or sometimes requested medical evaluation of a new outbreak. In the most recent outbreak, 72.2% had used combined therapy, regardless of the severity of the episode; 2-drug combinations were the most common. The majority of dermatologists prescribed combined therapy, most commonly a 2-drug combination for mild or minimal disease, and 3 or more drugs for moderate to very severe outbreaks.

Conclusions

Treatments used by patients for an outbreak of AD are similar to those prescribed by dermatologists in recent outbreaks.

Keywords:

Atopic dermatitis

Treatment

Patient attitude

Resumen

Introducción y objetivos

Conocer la actitud de los pacientes adultos frente a la dermatitis atópica (DA) y su tratamiento.

Material y métodos

Estudio transversal, multicéntrico, realizado en pacientes con al menos 2 brotes en el último año.

Resultados

Doscientos veintisiete dermatólogos reclutaron 1.441 pacientes analizables, mayoritariamente mujeres con 3,6 brotes al año de media. La mayoría de los pacientes (97,2%) indicó que solicitaba, al menos ocasionalmente, asesoramiento médico ante nuevos brotes. El 72,2% recurrió a la terapia combinada (TC) en el último brote, independientemente de su intensidad, siendo las combinaciones de 2 fármacos (TC2) las más utilizadas. Los dermatólogos indicaron mayoritariamente TC, siendo la TC2 más frecuente para formas leves y casi sin enfermedad, y la TC de más de 2 fármacos en brotes moderados a muy graves.

Conclusiones

Los tratamientos empleados por los pacientes ante un brote de DA son similares a los indicados por los dermatólogos.

Palabras clave:

Dermatitis atópica

Tratamiento

Actitud del paciente

Full text is only aviable in PDF

References

[1.]

A.Y. Finlay.

Quality of life in atopic dermatitis.

J Am Acad Dermatol, 45 (2002), pp. S64-S66

Medline

[2.]

G. Kiebert, S.V. Sorensen, D. Revicki, S.C. Fagan, J.J. Doyle, J. Cohen, et al.

Atopic dermatitis is associated with a decrement in health-related quality of life.

Int J Dermatol, 41 (2002), pp. 151-158

Medline

[3.]

M.L. Levy.

Atopic dermatitis: understanding the disease and its management.

Curr Med Res Opin, 23 (2007), pp. 3091-3103

http://dx.doi.org/10.1185/030079907X242593 | Medline

[4.]

I.I. Williams, C. Robertson, A. Stewart, N. Aït-Khaled, G. Anabwani, R. Anderson, et al.

Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood.

J Allergy Clin Immunol, 103 (1999), pp. 125-138

Medline

[5.]

H. Williams.

Epidemiology of atopic dermatitis: recent advances and future predictions.

Curr Probl Dermatol, 28 (1999), pp. 9-17

Medline

[6.]

H. Williams.

Epidemiology of atopic dermatitis.

Clin Exp Dermatol, 25 (2000), pp. 522-529

Medline

[7.]

B. Wuthrich.

Clinical aspects, epidemiology and prognosis of atopic dermatitis.

Ann Allergy Asthma Immunol, 83 (1999), pp. 464-470

http://dx.doi.org/10.1016/S1081-1206(10)62852-9 | Medline

[8.]

C.E. Correale, C. Walter, L.N. Murphy, T.J. Graig.

Atopic dermatitis: A review of diagnosis and treatment.

Am Fam Phys, 60 (1999), pp. 1191-1198

[9.]

J. Méndez-Cabeza, H. Alache, E. Cerrada.

Manejo de la dermatitis atópica en Atención Primaria.

Medifam, 13 (2003), pp. 75-84

[10.]

E. Baselga.

Tratamiento de la dermatitis atópica en la infancia.

Actas Dermosifiliogr, 94 (2003), pp. 345-355

[11.]

R.O. McAlister, S.J. Tofte, J.J. Doyle, A. Jackson, J.M. Hanifin.

Patient and physician perspectives vary on atopic dermatitis.

Cutis, 69 (2002), pp. 461-466

Medline

[12.]

C.R. Charman, A.J. Venn, H. Williams, M. Bigby.

Measuring atopic eczema severity visually.

Arch Dermatol, 141 (2005), pp. 1146-1151

http://dx.doi.org/10.1001/archderm.141.9.1146 | Medline

[13.]

E.D. Baron, D. Barzilai, G. Johnston, M. Kawashima, M. Takigawa, H. Nakagawa, et al.

Atopic dermatitis management: comparing the treatment patterns of dermatologists in Japan, USA and UK.

Br J Dermatol, 147 (2002), pp. 710-715

Medline

[14.]

L.F. Eichenfield, A.W. Lucky, M. Boguniewicz, R.G.B. Langley, R. Cherill, K. Marshall, et al.

Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents.

J Am Acad Dermatol, 46 (2002), pp. 495-504

Medline

[15.]

C. Ellis, T. Luger, D. Abeck, R. Allen, R.A.C. Graham-Brown, Y. De Prost, L.F. Einchenfield, C. Ferrándiz, on behalf of the ICCAD Faculty, et al.

International Consensus Conference on Atopic Dermatitis II (ICCAD II*): clinical update and current treatment strategies.

Br J Dermatol, 148 (2003), pp. 3-10

Medline

[16.]

D. Rudikoff.

Atopic dermatitis-Treatment Update.

US Dermatol Rev, (2006), pp. 1-5

[17.]

N. Barbier, C. Paul, T. Luger, R. Allen, Y. De Prost, K. Papp, et al.

Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1,550 patients from the pimecrolimus cream 1% randomized controlled trials programme.

Br J Dermatol, 150 (2004), pp. 90-102

Medline

Indexed in:

Follow us:

Indexed in:

Follow us:

Subscribe to our newsletter